Laffer CL - Search Results

1

Renal denervation in the antihypertensive arsenal - knowns and known unknowns.

Messerli FH, Bavishi C, Brguljan J, Burnier M, Dobner S, Elijovich F, Ferdinand KC, Kjeldsen S, Laffer CL, S Ram CV, Rexhaj E, Ruilope LM, Shalaeva EV, Siontis GCM, Staessen JA, Textor SC, Vongpatanasin W, Vogt L, Volpe M, Wang J, Williams B. Messerli FH, et al. Among authors: laffer cl. J Hypertens. 2022 Oct 1;40(10):1859-1875. doi: 10.1097/HJH.0000000000003171. J Hypertens. 2022. PMID: 36052518 Free PMC article.

2

Bayesian analysis supports use of ambulatory blood pressure monitors for screening.

Elijovich F, Laffer CL. Elijovich F, et al. Among authors: laffer cl. Hypertension. 1992 Feb;19(2 Suppl):II268-72. doi: 10.1161/01.hyp.19.2_suppl.ii268. Hypertension. 1992. PMID: 1735591

3

Magnitude, reproducibility, and components of the pressor response to the clinic.

Elijovich F, Laffer CL. Elijovich F, et al. Among authors: laffer cl. Hypertension. 1990 Feb;15(2 Suppl):I161-5. doi: 10.1161/01.hyp.15.2_suppl.i161. Hypertension. 1990. PMID: 2298472 Clinical Trial.

4

Suboptimal outcome of management of metabolic cardiovascular risk factors in Hispanic patients with essential hypertension.

Laffer CL, Elijovich F. Laffer CL, et al. Hypertension. 1995 Dec;26(6 Pt 2):1079-84. doi: 10.1161/01.hyp.26.6.1079. Hypertension. 1995. PMID: 7498972

5

Predictors of the pressor response to the clinic visit in essential hypertensives with and without diabetes mellitus.

Laffer CL, Elijovich F. Laffer CL, et al. Clin Auton Res. 1994 Dec;4(6):323-9. doi: 10.1007/BF01821533. Clin Auton Res. 1994. PMID: 7711468 Clinical Trial.

6

Regulation of growth of the adrenal gland in DOC-salt hypertension. Role of angiotensin II receptor subtypes.

Elijovich F, Zhao HW, Laffer CL, Du Y, DiPette DJ, Inagami T, Wang DH. Elijovich F, et al. Among authors: laffer cl. Hypertension. 1997 Jan;29(1 Pt 2):408-13. doi: 10.1161/01.hyp.29.1.408. Hypertension. 1997. PMID: 9039135

7

The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients.

Elijovich F, Laffer CL, Schiffrin EL. Elijovich F, et al. Among authors: laffer cl. J Hum Hypertens. 1997 May;11(5):313-9. doi: 10.1038/sj.jhh.1000438. J Hum Hypertens. 1997. PMID: 9205939 Clinical Trial.

8

Evidence for linkage between essential hypertension and a putative locus on human chromosome 17.

Baima J, Nicolaou M, Schwartz F, DeStefano AL, Manolis A, Gavras I, Laffer C, Elijovich F, Farrer L, Baldwin CT, Gavras H. Baima J, et al. Hypertension. 1999 Jul;34(1):4-7. doi: 10.1161/01.hyp.34.1.4. Hypertension. 1999. PMID: 10406815

9

Regulation of plasma endothelin by salt in salt-sensitive hypertension.

Elijovich F, Laffer CL, Amador E, Gavras H, Bresnahan MR, Schiffrin EL. Elijovich F, et al. Among authors: laffer cl. Circulation. 2001 Jan 16;103(2):263-8. doi: 10.1161/01.cir.103.2.263. Circulation. 2001. PMID: 11208687 Clinical Trial.

10

Participation of renal and circulating endothelin in salt-sensitive essential hypertension.

Elijovich F, Laffer CL. Elijovich F, et al. Among authors: laffer cl. J Hum Hypertens. 2002 Jul;16(7):459-67. doi: 10.1038/sj.jhh.1001419. J Hum Hypertens. 2002. PMID: 12080429 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters